Commit To Purchase Day One Biopharmaceuticals At $12.50, Earn 52.8% Annualized Using Options
March 22, 2024 at 11:35 AM EDT
Investors eyeing a purchase of Day One Biopharmaceuticals Inc (DAWN) stock, but cautious about paying the going market price of $15.12/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $12.50 strike, which has a bid at the time of this writing of $2.15..